BNTGF:OTC-Brenntag SE (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 99.03

Change

0.00 (0.00)%

Market Cap

USD 15.30B

Volume

3.00

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber material science industries. Brenntag SE was founded in 1874 and is based in Essen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-07-24 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SKFOF Sika AG

N/A

USD49.50B 48.94 34.34
SXYAY Sika AG

N/A

USD49.31B 48.77 34.34
GVDBF Givaudan SA

N/A

USD47.48B 51.02 36.04
GVDNY Givaudan SA

N/A

USD45.02B 51.33 36.04
KDSKF Koninklijke DSM N.V

N/A

USD35.65B 59.45 26.00
RDSMY Koninklijke DSM N.V

N/A

USD35.20B 58.93 26.66
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD31.93B 47.55 0.24
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD24.52B 51.81 42.97
AKZOY Akzo Nobel N.V

N/A

USD22.74B 22.48 17.18
AKZOF Akzo Nobel N.V

N/A

USD22.49B 22.23 17.18

ETFs Containing BNTGF

Symbol Name Weight Mer Price(Change) Market Cap
PHW:CA Purpose Fund Corp. - Purp.. 0.00 % 1.16 %

N/A

USD4.21M
IQQM:F iShares Public Limited Co.. 0.00 % 0.40 %

N/A

USD0.54B
F751:XETRA ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXV7:XETRA iShares (DE) I - iShares .. 0.00 % 0.46 %

N/A

USD0.08B
EXS3:XETRA iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

N/A

USD5,933.92B
ELF1:XETRA Deka MDAX UCITS ETF 0.00 % 0.00 %

N/A

USD0.44B
EL4X:XETRA Deka DAXplus Maximum Divi.. 0.00 % 0.30 %

N/A

USD0.24B
E907:XETRA Lyxor 1 - MDAX UCITS ETF 0.00 % 0.30 %

N/A

USD0.23B
DXSL:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.30 %

N/A

USD0.03B
C064:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
C007:XETRA Lyxor MDAX® (DR) UCITS E.. 0.00 % 0.30 %

N/A

USD0.27B
F751:F ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
PQIN PGIM ETF Trust - PGIM QMA.. 0.00 % 0.29 %

N/A

USD0.04B
EXV7:F iShares (DE) I - iShares .. 0.00 % 0.46 %

N/A

USD0.08B
EXS3:F iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

N/A

USD5,933.92B
ELF1:F Deka MDAX UCITS ETF 0.00 % 0.00 %

N/A

USD0.44B
EDMF:F iShares Edge MSCI EMU Mul.. 0.00 % 0.40 %

N/A

USD6.91M
E907:F Lyxor 1 - MDAX UCITS ETF 0.00 % 0.30 %

N/A

USD0.22B
C064:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
C007:F Lyxor MDAX® (DR) UCITS E.. 0.00 % 0.30 %

N/A

USD0.26B
XSNR:LSE Xtrackers - Stoxx Europe .. 0.00 % 0.30 %

N/A

USD0.03B
DJMC:LSE iShares Public Limited Co.. 0.00 % 0.40 %

N/A

USD0.55B
IQQM:XETRA iShares Public Limited Co.. 0.00 % 0.40 %

N/A

USD0.54B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.75% 69% D+ 60% D-
Dividend Return 2.05% 55% F 47% F
Total Return 27.80% 66% D 61% D-
Trailing 12 Months  
Capital Gain 57.73% 69% D+ 62% D-
Dividend Return 2.58% 53% F 36% F
Total Return 60.31% 68% D+ 63% D
Trailing 5 Years  
Capital Gain 97.65% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.65% 66% D 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.65% 55% F 52% F
Dividend Return 1.98% 64% D 51% F
Total Return 15.64% 50% F 52% F
Risk Return Profile  
Volatility (Standard Deviation) 35.92% 53% F 60% D-
Risk Adjusted Return 43.53% 66% D 69% D+
Market Capitalization 15.30B 87% B+ 92% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.87 44% F 28% F
Price/Book Ratio 3.46 43% F 34% F
Price / Cash Flow Ratio 12.55 31% F 17% F
EV/EBITDA 15.08 40% F 26% F
Management Effectiveness  
Return on Equity 12.32% 65% D 76% C
Return on Invested Capital 10.39% 64% D 73% C
Return on Assets 4.82% 68% D+ 83% B
Debt to Equity Ratio 41.45% 60% D- 40% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.12 36% F 40% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.